Sumito Ito
Impact in
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
-
- Pharmacological Effects and Toxicity Studies
Papers in
- Oncology 11
- Drug Transport and Resistance Mechanisms 10
-
- Pharmacological Effects and Toxicity Studies 6
- Neonatal Health and Biochemistry 1
- Co-authors
- Hiroyuki Kusuhara (12 shared papers)Yuichi Sugiyama (11 shared papers)Hiroaki Yuasa (3 shared papers)Katsuhisa Inoue (3 shared papers)Junko Toyoshima (1 shared paper)Yoshinori Moriyama (2 shared papers)Hideki Nakayama (1 shared paper)Chunyong Wu (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (4 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Pharmaceutical Research (1 paper)Drug Metabolism and Pharmacokinetics (1 paper)International Journal of Theoretical and Applied Finance (1 paper)
- Partner nations
- JapanSouth KoreaGermany
In The Last Decade
Sumito Ito
14 papers receiving 498 citations
Peers
Comparison fields: 5 of 72
- Oncology 346
- Pediatrics, Perinatology and Child Health 246
- Pharmacology 88
- Biochemistry 52
- Clinical Biochemistry 25
Countries citing papers authored by Sumito Ito
This map shows the geographic impact of Sumito Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumito Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumito Ito more than expected).
Fields of papers citing papers by Sumito Ito
This network shows the impact of papers produced by Sumito Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumito Ito. The network helps show where Sumito Ito may publish in the future.
Co-authors
The 25 scholars most cited alongside Sumito Ito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 168 | |
| 2 | 2010 | 112 | |
| 3 | 2013 | 55 | |
| 4 | 2015 | 37 | |
| 5 | 2010 | 36 | |
| 6 | 2013 | 20 | |
| 7 | 2013 | 19 | |
| 8 | 2012 | 16 | |
| 9 | 2017 | 16 | |
| 10 | 2017 | 9 | |
| 11 | 2018 | 8 | |
| 12 | 2020 | 6 | |
| 13 | 2014 | 1 | |
| 14 | 2005 | 1 |
About Sumito Ito
Sumito Ito is a scholar working on Oncology, Pediatrics, Perinatology and Child Health, Molecular Biology, Epidemiology and Infectious Diseases, having authored 14 papers that have together received 504 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (10 papers), Pharmacological Effects and Toxicity Studies (6 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Metabolism and Genetic Disorders (1 paper), Trace Elements in Health (1 paper), Hemoglobinopathies and Related Disorders (1 paper), Metabolism, Diabetes, and Cancer (1 paper) and Neonatal Health and Biochemistry (1 paper). The work is most often cited by research in Oncology (346 citations), Pediatrics, Perinatology and Child Health (246 citations), Pharmacology (88 citations), Biochemistry (52 citations) and Clinical Biochemistry (25 citations). Sumito Ito has collaborated with scholars based in Japan, South Korea and Germany. Frequent co-authors include Hiroyuki Kusuhara, Yuichi Sugiyama, Hiroaki Yuasa, Katsuhisa Inoue, Junko Toyoshima, Yoshinori Moriyama, Hideki Nakayama, Chunyong Wu, Tsunenori Kondo and Shigeru Horita. Their work appears in journals such as Journal of Pharmaceutical Sciences, Journal of Pharmacology and Experimental Therapeutics, Pharmaceutical Research, Drug Metabolism and Pharmacokinetics and International Journal of Theoretical and Applied Finance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.